(Q46979156)

English

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients

scientific article published on 27 September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Liyan Miao

1

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

Jian Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

Chenrong Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

Zhenya Shen

4

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

publication date

27 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

63

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

12

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

1135-1141

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

https://scigraph.springernature.com/pub.10.1007/s00228-007-0381-6

0 references

Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperat

1 reference

https://api.crossref.org/works/10.1007%2FS00228-007-0381-6

21 January 2018

The efficiency and safety of anticoagulation therapy in atrial fibrillation in Chinese

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flexible induction dose regimen for warfarin and prediction of maintenance dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interindividual variability in sensitivity to warfarin--Nature or nurture?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a warfarin initiation protocol for older people

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Warfarin dose related to apolipoprotein E (APOE) genotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

APOE genotype makes a small contribution to warfarin dose requirements.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and gamma-glutamyl carboxylase) gene variants with warfarin sensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the gene for vitamin K epoxide reductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/17899045

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-007-0381-6

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/17899045

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46979156&oldid=2147866447"